5k01: Difference between revisions
Jump to navigation
Jump to search
New page: '''Unreleased structure''' The entry 5k01 is ON HOLD Authors: Ehler, A., RODRIGUEZ-SARMIENTO, R.M., Rudolph, M.G. Description: Crystal Structure of COMT in complex with 2,7-dimethyl-3-... |
No edit summary |
||
| (3 intermediate revisions by the same user not shown) | |||
| Line 1: | Line 1: | ||
==Crystal Structure of COMT in complex with 2,7-dimethyl-3-(1H-pyrazol-3-yl)imidazo[1,2-a]pyridine== | |||
<StructureSection load='5k01' size='340' side='right'caption='[[5k01]], [[Resolution|resolution]] 1.38Å' scene=''> | |||
== Structural highlights == | |||
<table><tr><td colspan='2'>[[5k01]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Rattus_norvegicus Rattus norvegicus]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5K01 OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5K01 FirstGlance]. <br> | |||
</td></tr><tr id='method'><td class="sblockLbl"><b>[[Empirical_models|Method:]]</b></td><td class="sblockDat" id="methodDat">X-ray diffraction, [[Resolution|Resolution]] 1.383Å</td></tr> | |||
<tr id='ligand'><td class="sblockLbl"><b>[[Ligand|Ligands:]]</b></td><td class="sblockDat" id="ligandDat"><scene name='pdbligand=6OW:2,7-DIMETHYL-3-(1H-PYRAZOL-5-YL)IMIDAZO[1,2-A]PYRIDINE'>6OW</scene>, <scene name='pdbligand=K:POTASSIUM+ION'>K</scene></td></tr> | |||
<tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5k01 FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5k01 OCA], [https://pdbe.org/5k01 PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5k01 RCSB], [https://www.ebi.ac.uk/pdbsum/5k01 PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5k01 ProSAT]</span></td></tr> | |||
</table> | |||
== Function == | |||
[https://www.uniprot.org/uniprot/COMT_RAT COMT_RAT] Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol. | |||
==See Also== | |||
*[[Catechol O-methyltransferase 3D structures|Catechol O-methyltransferase 3D structures]] | |||
__TOC__ | |||
[[Category: | </StructureSection> | ||
[[Category: Ehler | [[Category: Large Structures]] | ||
[[Category: Rodriguez-Sarmiento | [[Category: Rattus norvegicus]] | ||
[[Category: Rudolph | [[Category: Ehler A]] | ||
[[Category: Rodriguez-Sarmiento RM]] | |||
[[Category: Rudolph MG]] | |||
Latest revision as of 22:16, 20 September 2023
Crystal Structure of COMT in complex with 2,7-dimethyl-3-(1H-pyrazol-3-yl)imidazo[1,2-a]pyridineCrystal Structure of COMT in complex with 2,7-dimethyl-3-(1H-pyrazol-3-yl)imidazo[1,2-a]pyridine
Structural highlights
FunctionCOMT_RAT Catalyzes the O-methylation, and thereby the inactivation, of catecholamine neurotransmitters and catechol hormones. Also shortens the biological half-lives of certain neuroactive drugs, like L-DOPA, alpha-methyl DOPA and isoproterenol. See Also |
| ||||||||||||||||||